Modern Concepts in Heart Transplantation

Journal of Long-Term Effects of Medical Implants

Volumn 13, Issue 6, 2003, Pages 465-483

  Ellman, Peter I ^a,b   Ronson, Russell S ^a   Kron, Irving L ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b NONE   (United States)

Author keywords

Angiotensin; Cardiac allograft vasculopathy; Cardiac surgery; Cyclosporine; Donor cardiectomy; Donor recipient matching; Heart failure; Heart transplantation; Immunosuppression; Organ preservation; Ventricular assist device; Xenotransplantation

Indexed keywords

CARDIOLOGY; HEART VALVE PROSTHESES; IMMUNOLOGY;

HEART FAILURES;

TRANSPLANTATION (SURGICAL);

ANTIHISTAMINIC AGENT; ANTILIPEMIC AGENT; AZATHIOPRINE; CALCIUM CHANNEL BLOCKING AGENT; CORTICOSTEROID; CYCLOSPORIN; CYTOMEGALOVIRUS ANTIBODY; IMMUNOSUPPRESSIVE AGENT; ISOPRENALINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PARACETAMOL; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; BONE MARROW SUPPRESSION; CARDIAC ALLOGRAFT VASCULOPATHY; CHRONIC GRAFT REJECTION; CONCEPT FORMATION; CONGESTIVE HEART FAILURE; CORONARY ARTERY BYPASS SURGERY; GASTROINTESTINAL SYMPTOM; GLUCOSE INTOLERANCE; GRAFT REJECTION; HEART MUSCLE BIOPSY; HEART PRESERVATION; HEART TRANSPLANTATION; HISTORY OF MEDICINE; HLA TYPING; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MORBIDITY; MORTALITY; NEPHROTOXICITY; NEUROTOXICITY; NONHUMAN; ORGAN DONOR; ORTHOTOPIC TRANSPLANTATION; PATHOPHYSIOLOGY; PATIENT SELECTION; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PREDICTION; PREOPERATIVE EVALUATION; PREVALENCE; RECIPIENT; REVIEW; RISK FACTOR; SIDE EFFECT; SURGICAL TECHNIQUE; SURVIVAL; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TREATMENT OUTCOME; UNITED STATES; VASCULAR DISEASE; XENOTRANSPLANTATION;

FEMALE; FORECASTING; GRAFT REJECTION; GRAFT SURVIVAL; HEART FAILURE, CONGESTIVE; HEART TRANSPLANTATION; HUMANS; MALE; MONITORING, PHYSIOLOGIC; ORGAN PRESERVATION; PATIENT SELECTION; PROGNOSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS; TRANSPLANTATION IMMUNOLOGY; TREATMENT OUTCOME; UNITED STATES;

EID: 0345872364     PISSN: 10506934     EISSN: None     Source Type: Journal    
DOI: 10.1615/JLongTermEffMedImplants.v13.i6.40     Document Type: Review

References (80)

1. Miller LW, Missov ED. Epidemiology of heart failure. Cardiol Clin 2001; 19(4):547-555.
2. Kannel WB, Belanger AJ. Epidemiology of heart failure. Am Heart J 1991; 121:951-957.
3. Ho KKL, Anderson KM, Kannel WB. Survival after the onset of congestive heart failure in Framingham Heart Study Subjects. Circulation 1993; 88:107-115.
4. Haldeman GA, Croft JB, Giles WH. Hospitalization of patients with heart failure: National Hospital Discharge Survey, 1985 to 1995. Am Heart J 1999; 137:352-360.
5. Malek M. Health economics of heart failure. Heart 1999; 82:IV11-IV13.
6. O'Connel JB, Bristow MR. Economic impact of heart failure in the United States: time for a different approach. J Heart Lung Transplant 1994; 13 (Suppl):107-112.
7. Cope JT, Kaza AK, Reade CC, Shockey KS, Kern JA, Tribble CG, Kron IL. A cost comparison of heart transplantation versus alternative operations for cardiomyopathy. Ann Thorac Surg 2001; 72(4):1298-1305.
8. Katz AM. Evolving concepts of heart failure: cooling furnace, malfunctioning pump, enlarging muscle. Part II: Hypertrophy and dilatation of the failing heart. J Card Fail 1998; 4(1):67-81.
9. Anversa P, Kajsturea J, Olivetti G. Myocyte death in heart failure. Curr Opin Cardiol 1996; 11:245-251.
10. Middlekauff HR. Mechanisms and implications of autonomic nervous system dysfunction in heart failure. Curr Opin Caridol 1997; 12:265-275.
11. Moser DK. Pathophysiology of heart failure update: the role of neurohumoral activation in the progression of heart failure. Am Assoc Clin Nurs Clin Issues 1998; 91:57-71.
12. Oparil, S. Pathogenesis of ventricular hypertrophy. J Am Coll Cardiol 1985; 5:56B.
13. th Bethesda conference: Cardiac Transplantation. J Am Coll Cardiol 1993; 22 (Suppl 1):1-64.
14. Olivari MT, Antolick A, Kay MP, Jameison SW, Ring WS. Heart transplantation in elderly patients. J Heart Lung Transplant 1988; 7:258-264.
15. Kron IL, Tribble CG, Kern JA, Daniel TM, Rose CE, Truwit JD, Blackbourne LH, Bergin JD. Successful transplantation of marginally acceptable thoracic organs. Ann Surg 1993; 217(5):518-522.
16. Ott GY, Norman DJ, Hosenpud JD, Hershberge RE, Ratkovec RM, Cobanoglu A. Heart transplant in patients with previous heart operations. Excellent clinical results. J Thorac Cardiovasc Surg 1994; 107:203-209.
17. Sethi GK, Lanauze P, Rosado LJ, Huston C, McCarthy MS, Butman S, Copeland JG. Clinical significance of weight difference between donor and recipient in heart transplantation. J Thorac Cardiovasc Surg 1993; 106:444.
18. Cummings D, Contreras M, Amin S, Halil O, Downham B, Yacoub MH. Red cell alloantibody development associated with heart and lung transplantation. Transplantation 1995; 59:1432.
19. Loh E, Bergin JD, Cvouper GS, Mudge GH Jr. Role of panel reactive antibody cross-reactivity in predicting survival in orthotopic heart transplantation. J Heart Lung Transplant 1994; 13:194.
20. Katz AM, Reuter H. Cellular calcium and cardiac cell death. Am J Cardiol 1979; 44:188-190.
21. Naylor WG. The role of calcium in the ischemic myocardium. Am J Pathol 1981; 102:262-270.
22. Pool Wilson PA, Harding DP, Bourdillon PDV, Tones MA. Calcium out of control. J Mol Cell Cardiol 1984; 16:175-187.
23. Young JB, Naftel DC, Bourge RC, Kirklin JK, Clemson BS, Porter CB, Rodeheffer RJ, Kenzora, JL. Matching the heart donor and heart transplant recipient. Clues for successful expansion of the donor pool:a multivariable, multiinstitutional report. J Heart Lung Transplant 1994; 13:365
24. Dreyfus G, Jebara V, Milhaileanu S, Carpenter AF. Total orthotopic heart transplantation: an alternative to the standard technique. Ann Thorac Surg 1991; 52:1181-1184.
25. Blanche C, Czer LSC, Valenzo M, Trent A. Alternative technique for orthotopic heart transplantation. Ann Thorac Surg 1994; 57:765-767.
26. Blanche C, Valenza M, Czer LSC, Barath P, Asmon D, Harasty D, Utley C, Freimark D, Aleksic I, Matloff J, Trento A. Orthotopic heart transplantation with bicaval and pulmonary venous anastomoses. Ann Thorac Surg 1994; 58:1505-1509.
27. Freimark D, Silverman JM, Aleksic I, Crues JV, Blanche C, Trento A, Admon D, Queral CA, Harasty DA, Czer LSC. Atrial emptying with orthotopic heart transplantation using bicaval and pulmonary venous anstomoses: a magnetic resonance imaging study. J Am Coll Cardiol 1995; 25:932-936.
28. Buja G, Miorelli M, Livi U. Complete atrioventricular block after orthotopic heart transplantation: incidence, elctrocardiographic-electrophysiological evaluation and clinical importance. Eur J Cardiac Pacing Electrophysiol 1992; 3:173-179.
29. DiBiase A, Tse TM, Schnittger I, Wexler L, Stinson EB, Valentine HA. Frequency and mechanism of bradycardiain cardiac transplant recipients and need for pacemakers. Am J Cardiol 1991; 67:1385-1389.
30. Holt ND, McComb JM. Late atrioventricular block and permanent pacemaker implantation after orthotopic cardiac transplantation. PACE 1996; 19:1272.
31. Dupont E, Schandene L, Denys C, Wybran J. Differential in vitro actions of cyclosporin, methylprednisolone, and 6-mucaptopurine; implications for drugs' influence on lymphatic mechanisms. Clin Immunol Immunopathol 1986; 40:422-428.
32. Halloran PF, Lui SL. Approved immunosuppressants. In Norman DJ, Suki WN, editors. Primer on Transplantation. Thorofare, NJ: American Society of Transplant Physicians, 1998.
33. Davis M, Williams R, Chakroborty J, English J, Marks Video G, Tempini S. Prednisone or prednisolone for the treatment of chronic active hepatitis? A comparison of plasma availability. Br J Clin Pharmacol 1978; 5:501-505.
34. Kahan BD, Welsh M, Rutzky LP. Challenges in cyclosporine therapy: the role of therapeutic monitoring by area under the curve monitoring. Ther Drug Monit 1995; 17:621-624.
35. Morris R. Modes of action of FK506, cyclosporine A, and rapamycin. Transplant Proc 1994; 26:3272-3275.
36. Hess A. Cyclosporine in clinical use. New York: World Medical Press, 1988.
37. Bennett Wm, Porter JA. Cyclosporine-associated hypertension. Am J Med 1988; 85:131-133.
38. Chapman JR, Marcen R, Arias M, Raine AEG, Dunhill MS, Morris PJ. Hypertension after renal transplantation. Transplantation 1987; 43:860-864.
39. Curtis JJ, Luke RG, Jones P, Diethelm AG. Hypertension in cyclosporine treated renal transplant recipients is sodium dependent. Am J Med 1988; 85:134-138.
40. Jain AB, Venktaramanan R, Cadoff E, Fung JJ, Todo S, Krajack A, Starzl TE. Effect of hepatic dysfunction and tube clamping on FK506 pharmacokinetics and trough concentrations. Transplant Proc 1990; 22:57-59.
41. Jordan ML, Shapiro R, Vivas CA, Scantlebury VP, Rhandhawa P, Carrieri G, McCuauley J. FK506 "rescue" for resistant rejection of renal allografts under primary cyclosporine immunosuppression. Transplantation 1994; 57:860-865.
42. Bach JF. The mode of action of immunosuppressive agents. Oxford: North Holland, 1975.
43. Allison AC, Hovi T, Watts RWE, Webster ADB. Immunologic observations on patients with Lesch-Nyhan syndrome, and on the role of de novo purine synthesis in lymphocyte transformation. Lancet 1975; 2:1179-1183
44. Allison AC, Hovi T, Watts RWE, Webster ADB. The role of de novo purine synthesis in lymphocyte transformation. Ciba Foundation Symposium 1977; 48:207-224.
45. Eugui EM, Almquist SJ, Muller CD, Allison AC. Lymphocyte selective cytostatic, and immunosuppressive effects of mycophenolic acid in vitro: role of deoxyguanisine nucleotide depletion. Scand J Immunol 1991; 33:175-183.
46. Penn I. Neoplastic complications of organ transplantation. In: Ginns LC, Cosimi AB, Morris PJ. Transplantation. Malden, MA: Blackwell Science, 1999.
47. Billingham ME. Diagnosis of cardiac rejection by endomyocardial biopsy. J Heart Transplant 1982; 1:25-30.
48. Basile L, Zerbe T, Rabin B, Clarke J, Abrams A, Cerilli J. Identification of the antibody to vascular endothelial cells in patients undergoing cardiac transplantation. Transplantation 1985; 40:670-674.
49. Jarcho J, Naftel DC, Shroyer TW, Kirklin JK, Bourge RC, Barr ML, Pitts DG, Starling RC. Influence of HLA mismatch on rejection after heart transplantation. A multi-institutional study. The Cardiac Transplant Datatbase Group. J Heart Lung Transplant 1997; 16:801-812.
50. Kirklin JK, Naftel DC, Bourge RC, White-Williams CW, Caulfield JR, Takka MR, Holman WL, Zorn GL. Rejection after cardiac transplantation. Circulation 1992; 86S:236-241.
51. Kubo SH, Naftel DC, Mills RM, O'Donnell J, Rodeheffer RJ, Cintron GB, Kenzora JL, Bourge RC, Kirklin JK. Risk factors for late recurrent rejection after heart transplantation: a multi-institutional, multi-variable analysis. J Heart Lung Transplant 1995; 14:409-418.
52. Renlund DG, Gilbert E, O'Connell JB, Gay WA, Jones KW, Burton NA, Doty DB, Karwande SV, DeWitt C, Menlove RL, Herrick CM, Bristow MR. Age-associated decline in cardiac allograft rejection. Am J Med 1987; 83:391-398.
53. Crandall BG, Renlund DG, O'Connell JB, Burton NA, Jones KW, Gay WA, Doty DB, Karwande SV, Lee HW, Holland C, Menlove RL, Hammond E, Bristow MR. Increased cardiac allograft rejection in female heart transplant recipients. J Heart Lung Transplant 1988; 7:419-423.
54. Keough A, Valentine HA, Humst SA, Schroeder JS, Oyer PE. Increased rejection in gender-mismatched grafts: amelioration by triple therapy. J Heart Lung Transplant 1991; 10:375-381.
55. Kobashigawa JA, Kirklin JK, Naftel DC, Bourge RC, Ventura HO, Mohanty PK, Cintron GB, Bhat, G, and The Transplant Research Database. Pretransplantation risk factors for acute rejection after heart transplantation: a multi-institutional study. J Heart Lung Transplant 1993; 12:355-366.
56. Sheldon ST, Hasleton PS, Yonan NA, Rhaman AN, Deiraniya AK, Campbell CS, Brooks NH, Dyer PA. Rejection in heart transplantation strongly correlates with HLA-DR antigen mismatch. Transplantation 1994; 58:719-722.
57. Lopez C, Simmons RL, Mauer SM, Najarian JS, Good RA. Association of renal allograft rejection with virus infections. Am J Med 1974; 56:280-289.
58. Hammond EH, Yowell RL, Nonoda S, Manlove RL, Renlund DG, Bristow MR, Gay WA, Jones KW, O'Connell JB. Vascular (humoral) rejection in heart transplantation: pathologic observations and clinical implications. J Heart Lung Transplant 1989; 8:4430-4443.
59. Lones MA, Czer LS, Trento A, Harasty D, Miller JM, Fishbein MC. Clinical-pathologic features of humoral rejection in cardiac allografts; a study in 81 consecutive patients. J Heart Lung Transplant 1995; 14:151-162.
60. Smith SH, Kirklin JK, Geer J, Abadal ML, Caulfield JB, McGiffin DC. Arteritis in cardiac rejection after transplantation. Am J Cardiol 1987; 59:1171-1173.
61. Gulick T, Chung MK, Pieper SJ, Lange LG, Schreiner GF. Interleukin-1 and tumor necrosis factor inhibit cardia myocyte beta-adrenergic responsiveness. Proc Natl Acad Sci USA 1989; 86:6753-6757.
62. Hosenpud JD, Campbell SM, Mendelson DJ. Interleukin-1 induced myocardial depression in an isolated heart preparation. J Heart Lung Transplant 1989; 8:460-464.
63. Yeoh TK, Frist WHY, Eastburn TE, Atkinson J. Clinical significance of mild rejection of the cardiac allograft. Circulation 1992; 86:2267-2271.
64. Beiber CP, Stinson EB, Shumway NE, Payne R, Kosek J. Cardiac transplantation in man. VII. Cardiac allograft pathology. Circulation 1970; 61:753-772.
65. Johnson DE, Gao SC, Schroeder JS, DeCampli WM, Billingham ME. The spectrum of coronary artery pathologic findings in human cardiac allografts. J Heart Lung Transplant 1989; 8:349-359.
66. Billingham ME. Cardiac transplant atherosclerosis. Transplant Proc 1987; 19:19-25.
67. Demetris AL, Zerbe T, Banner B. Morphology of solid organ allograft arteriopathy: identification of proliferating intimal cell populations. Transplant Proc 1989; 21:3667-3669.
68. Gao SZ, Alderman E, Schroeder J, Silverman JF. Accelerated coronary vascular disease in the heart transplant patient: coronary angiographic findings. J Am Coll Cardiol 1988; 12:334-340.
69. Gao SZ, Schroeder J, Alderman EL. Prevalence of accelerated coronary artery disease in heart transplant survivors: a comparison of cyclosporine and azathioprine regimens. Circulation 1989; 80 (Suppl III):100
70. Costanzo MR, Naftel DC, Pritzker MR, Heilman JK, Boehmer JP, Brozena SC, Dec GW, Ventura HO, Kirklin JK, Bourge RC, Miller LW. The cardiac transplant research database: heart transplant coronary artery disease detected by coronary artery angiography: a multi-institutional study of preoperative donor and recipient risk factors. J Heart Lung Transplant 1998; 17:744-753.
71. Fraund S, Pethig K, Franke U, Wahlers T, Harringer W, Cremer J, Fleguth HG, Oppelt P, Haverich A. Ten year survivial after heart transplantation: palliative procedure or successful long term treatment? Heart 1999; 82:47-51.
72. Naftel, D. Survival After Heart Transplantation. In: Kirklin J, Young J, McGiffin D, editors. Heart Transplantation. New York: Churchill Livingstone, 2002.
73. Elefteriades JA, Tolis G Jr, Levi E, Mills LK, Zaret BL. Coronary artery bypass grafting in severe left ventricular dysfunction: excellent survival with improved ejection fraction and functional state. J Am Coll Cardiol 1993; 22:1411-1417.
74. Kron IL, Flanagan TL, Blackbourne LH, Schroeder RA, Nolan SP. Coronary revascularization rather than cardiac transplantation for chronic ischemic cardiomyopathy. Ann Surg 1989; 210:348-354.
75. Rahimtoola SH. The hibernating myocardium. Am Heart J 1989; 117:211-221.
76. Dor V, Kreitmann P, Jourdan J. Interest in physiologic closure of left ventricle after resection and endocardiectomy for aneurysm of akinetic zone comparison with classical technique about a series of 209 left ventricular resections. J Cardiovasc Surg 1985; 26:73.
77. David TE, Uden DE, Strauss HD. The importance of the mitral apparatus in left ventricular function after correction of MR. Circulation 1983; 68(3):1176-1182.
78. Goldman ME, Mora F, Guarino T, et al. Mitral valvuloplasty is superior to valve replacement for preservation of LV function: an intraoperative two-dimensional echocardiographic study. J Am Coll Cardiol 1987; 10(3):568-575.
79. Bolling SF, Pagani FD, Deeb GM, Bach DS. Intermediate-term outcome of mitral reconstruction in cardiomyopathy. J Thorac Cardiovasc Surg 1998; 115:381-386.
80. Hardy JD, Kurrus FE, Chaves CM, Neely WA, Eraslan S, Turner MD, Fabian LW, Lavecki TD. Heart transplantation in man: developmental studies and report of a case. JAMA 1964; 188:1132-1140.